China Medical GatewayLoading your healthcare gateway…

Li Yin

Li Yin — Chief Physician — Thoracic Surgery — Medical Academy Cancer Hospital

Specialties

Specializes in minimally invasive surgical treatment and comprehensive diagnosis and treatment of complex thoracic diseases such as esophageal cancer, cardia cancer, lung cancer, and mediastinal tumors. Pioneered internationally the minimally invasive technique for esophageal cancer and the 'tube-free, non-restrictive' accelerated recovery approach and model. After minimally invasive surgery, there is no need for a gastric tube for nutrition; patients can eat orally and get out of bed on the second day post-surgery and can be discharged in 5-7 days. Patients who undergo lung cancer surgery can be discharged in 3-5 days. After minimally invasive mediastinal tumor surgery through the sub-xiphoid approach without thoracic incision, no drainage tube is required, and patients can be discharged 1-2 days post-surgery.

Education

Graduated from West China School of Medicine, Sichuan University in 2004, and obtained a Doctorate in Clinical Medicine.

Professional Experience

Director of the Esophageal and Mediastinal Tumor Surgery Department at the Cancer Hospital of the Chinese Academy of Medical Sciences, chief physician, professor, Doctor of Medicine, doctoral supervisor, Fellow of the Royal College of Surgeons of the United Kingdom, chief expert of the national advanced training program for minimally invasive esophageal cancer surgery, and expert enjoying the special government allowance from the State Council. Skilled in the diagnosis and routine surgical treatment of lung cancer, esophageal cancer, gastric cardia cancer, mediastinal tumors, chest wall tumors, and difficult thoracic diseases, as well as minimally invasive surgical treatment of benign and malignant tumors of the esophagus, lungs, and mediastinum under thoracoscopy. Expert in minimally invasive thoracoscopic surgery, the international pioneer of the esophageal cancer “tube-free and fasting-free” technique and model, allowing patients to get out of bed and eat orally on the first day after esophageal cancer surgery without the need for routine nasogastric tubes, nasoenteric tubes, chest drains, and other tubes, with discharge possible in 5 to 7 days post-surgery. Lung cancer surgery patients can be discharged in 3 to 5 days, while mediastinal tumors, benign thoracic tumors, and lung bullae surgeries allow discharge in 1 to 2 days. Tube-free, pain-free surgery, enhanced recovery techniques, internationally leading. Regularly holds nationwide minimally invasive technology training courses.

Professional Roles

Chairman of the Central and Western China Lung Cancer Collaboration Alliance of Thoracic Surgery, Deputy Director of the Esophageal Cancer Committee of the China Anti-Cancer Association, Member of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association, Leader of the Esophageal Cancer Study Group, Leader of the Esophageal Surgery Group of the China International Exchange and Promotive Association for Medical and Health Care, Chairman of the Esophageal Cancer Expert Committee and the Enhanced Recovery Expert Committee of the Chinese Medical Doctor Association, Deputy Director of the Thoracic Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care

Return to Home